News

Tissue Regenix Group Expects Positive First-Half Earnings

1 Mins read

London, UK – Tissue Regenix Group, a leading medical-devices company, has announced that it is on track to meet its targets for 2023. The company anticipates that its adjusted earnings for the first half of the year will be positive following a significant increase in revenue.

With revenue estimated at approximately $14.1 million for the six months ending June 30, Tissue Regenix Group has achieved a record high and a notable 19% year-on-year growth.

Moreover, the company expects to report positive adjusted earnings before interest, taxes, depreciation, and amortization (Ebitda) for the period. This follows their achievement of adjusted Ebitda profitability in the final quarter of 2022.

“We are optimistic about our future prospects and remain committed to our growth objectives,” stated Chief Executive Daniel Lee confidently. Adding further assurance, he emphasized that the company has ample financial resources to support its plans.

Tissue Regenix Group’s anticipated success in the first half of the year sets a positive trajectory for the remainder of 2023 and beyond.

Related posts
News

IMF commends Sri Lanka's new govt for reform continuation

1 Mins read
COLOMBO, Apr 25: The International Monetary Fund (IMF) on Friday commended the Sri Lankan government, led by President Anura Kumara Dissanayake, for…
News

U.S. Federal Reserve revokes crypto guidance for banks

1 Mins read
25th April 2025 – (Washington) The U.S. Federal Reserve announced on 24th April that it will withdraw previous guidance requiring state member…
News

Largo Reports Q1 2025 Production and Sales Results; Provides Update on Operational Turnaround Plans By Investing.com

7 Mins read
All dollar amounts expressed are in thousands of U.S. dollars unless otherwise indicated. Q1 2025 HighlightsBest Forex Trading Robots For 2022 TORONTO–(BUSINESS…

Leave a Reply

Your email address will not be published. Required fields are marked *